Regencell Bioscience Holdings Ltd

Healthcare · Drug Manufacturers - Specialty & Generic

6.20$ +0.3% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Income Statement

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

Tick rows to compare them in a chart (up to 4)

Income Statement RGC
Line item	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	2,140	2,489	2,468	2,516	2,598	2,661	2,771	2,894	2,808	2,682	2,824	3,038	2,990	3,127	3,197	3,163	0.0	0.0	0.0	0.0	0.0	0.0	–
Cost of Revenue	84	92	94	96	104	103	106	1,157	101	96	101	111	111	1,208	1,227	123	–	0.0	0.0	0.6	0.8	0.7	0.4
Gross Profit	2,056	2,397	2,374	2,420	2,494	2,558	2,665	1,737	2,707	2,586	2,723	2,927	2,879	1,920	1,970	3,040	–	0.0	0.0	-0.6	-0.8	-0.7	-0.4
Research & Development	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.2	0.4	0.4	2.5	1.6	1.1	0.9
Selling, General & Administrative	65	62	63	61	65	63	62	443	67	66	69	74	74	500	512	87	0.2	0.3	0.9	5.1	4.4	2.8	2.4
Total Operating Expenses	1,856	2,110	2,146	2,247	2,289	2,339	2,487	1,423	1,233	1,042	1,054	1,159	1,194	1,581	1,626	1,310	0.4	0.8	1.4	7.6	6.3	4.0	3.4
Operating Income	283	379	321	269	308	322	284	313	216	221	334	340	306	339	344	272	-0.4	-0.8	-1.4	-7.6	-6.3	-4.7	-3.8
Interest Expense	61	72	95	117	125	112	124	153	–	–	–	–	–	–	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–
Pre-Tax Income	208	306	142	152	144	605	123	157	76	58	236	265	179	253	282	214	-0.4	-0.8	-1.3	-7.6	-6.1	-4.4	-3.6
Income Tax Expense	89	121	59	60	57	242	50	62	49	18	91	107	73	100	111	102	0.0	0.0	-0.2	-0.2	-0.2	0.3	–
Net Income	117	185	82	91	86	363	72	96	78	40	145	158	106	153	170	112	-0.4	-0.8	-1.3	-7.4	-5.9	-4.3	-3.6
EBITDA	401	392	220	233	215	676	200	512	353	260	422	469	391	470	512	469	-0.4	-0.8	-1.4	-7.0	-5.3	-3.6	-3.2

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?